Hydrogen Therapy and Cancer Treatment – What a 2023 Systematic Review Found
A 2023 systematic review of 27 studies found molecular hydrogen improved survival rates, reduced chemotherapy side effects, and slowed tumour growth across multiple cancer types — positioning H₂ therapy as a meaningful complement to conventional cancer care.
Red Light Therapy and Multiple Health Outcomes — What an Umbrella Review of 204 Trials Found
A 2025 umbrella review of 204 randomised controlled trials found photobiomodulation significantly improved outcomes across nine health conditions — with the strongest evidence for fibromyalgia, knee osteoarthritis, cognitive function, and hair density. Here is what the evidence shows.
Hydrogen Water and Athletic Recovery — What an Elite Athlete Trial Found
A 2012 randomised, double-blind, placebo-controlled crossover trial in Medical Gas Research tested hydrogen-rich water in 10 elite male soccer players performing intense cycle exercise. Pre-exercise HRW blunted the rise in blood lactate during exercise and protected peak torque decline — pointing to a measurable effect on muscle fatigue at high intensities.
Red Light Therapy and Skin Ageing — What a 30-Session Controlled Trial Found
A 2014 controlled trial in Photomedicine and Laser Surgery tested red and near-infrared light therapy in 136 participants over 30 sessions across fifteen weeks. Both light-treated groups showed significant improvements in skin complexion, roughness, patient satisfaction, and ultrasound-measured intradermal collagen density compared with untreated controls.
Hydrogen Therapy and Brain Health — A Review of the Evidence
A review of the current evidence on molecular hydrogen and brain health — covering stroke recovery, traumatic brain injury, vascular dementia, and cognitive aging. What the research shows, and what it doesn’t.
Red Light Therapy and Oral Mucositis — What a Meta-Analysis of 14 Trials Found
A 2024 systematic review and meta-analysis in Head & Neck pooled 14 randomised trials covering 869 head and neck cancer patients receiving chemoradiotherapy. Photobiomodulation significantly reduced the incidence and severity of oral mucositis from the second week of treatment onward — supporting its use as an evidence-based supportive-care intervention.
Hydrogen Inhalation and COPD Exacerbations — What a 10-Centre Trial Showed
A 2021 multicentre, randomised, double-blind controlled trial in Respiratory Research tested adjunct hydrogen/oxygen inhalation across 10 Chinese hospital centres in patients with acute COPD exacerbations. The hydrogen group showed significantly faster improvement in breathlessness, cough and sputum severity compared with oxygen alone, with a clean safety profile.
Red Light Therapy and Hashimoto’s Thyroiditis — What a Randomised Trial Found
A 2013 randomised, placebo-controlled trial in Lasers in Medical Science treated 43 patients with hypothyroidism from chronic autoimmune (Hashimoto’s) thyroiditis with 10 sessions of low-level infrared laser. The laser group showed improved thyroid function, lower thyroid peroxidase antibody levels, and reduced levothyroxine dose requirements — with the benefits sustained at six-year follow-up.
Hydrogen Therapy and Type 2 Diabetes — What an Early Clinical Trial Found
A 2008 randomised, double-blind, placebo-controlled crossover trial in Nutrition Research tested hydrogen-rich water in 36 adults with type 2 diabetes or impaired glucose tolerance. Eight weeks of drinking 900 mL/day produced significant reductions in modified LDL cholesterol, small dense LDL and oxidative stress markers — and normalised the glucose tolerance test in 4 of 6 patients with impaired glucose tolerance.
Red Light Therapy and Diabetic Nerve Pain — What a 200-Patient Trial Found
A 2025 single-blinded randomised controlled trial in 200 patients with diabetic peripheral neuropathy tested ten daily sessions of low-level helium-neon laser therapy against sham. The active group showed significant reductions in neuropathic pain, improved protective foot sensation and quality of life, with neuron-specific biomarkers shifting in the same direction.